https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Spine Biomaterials

Showing all 13 results

Orthobiologics Market Analysis, Size, Trends | China | 2020-2026 | MedSuite

In 2020, the Chinese orthobiologics market size was valued at $460.7 million, with over 424,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 6% to reach $690.8 million in 2026. Throughout this medical market research, we analyzed 28 orthobiologics companies across China

more...

Orthobiologics Market Analysis, Size, Trends | India | 2020-2026 | MedSuite

In 2020, the Indian orthobiologics market size was valued at $76.2 million, with over 520,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 12.4% to reach $172.3 million in 2026. Throughout this medical market research, we analyzed 23 orthobiologics companies across India

more...

Orthobiologics Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite

In 2020, the Japanese orthobiologics market size was valued at $426.9 million, with over 221,000 bone grafting procedures performed every year. The market size is expected to fluctuate over the forecast period with a -0.4% compound annual growth rate (CAGR). Throughout this medical market research, we analyzed 16 orthobiologics companies across Japan and used our

more...

Orthobiologics Market Analysis, Size, Trends | South Korea | 2020-2026 | MedSuite

In 2020, the South Korean orthobiologics market size was valued at $141.6 million, with over 200,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $181.5 million in 2026. Throughout this medical market research, we analyzed 16 orthobiologics companies across

more...

Orthobiologics Market Analysis, Size, Trends | Australia | 2020-2026 | Medsuite

In 2020, the Australian orthobiologics market size was valued at $63.8 million, with over 29,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 4.9% to reach $89.4 million in 2026. Throughout this medical market research, we analyzed 48 orthobiologics companies across Australia

more...

Orthopedic Biomaterials Market Size, Share and COVID-19 Impact Analysis | Europe | 2022-2028 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more

The European Orthopedic Biomaterials market report covers and includes the Bone Graft Substitutes Market, Orthopedic Growth Factor Market , Orthopedic Cell Therapy Market, Hyaluronic Acid Viscosupplementation Market, and the Orthopedic Cartilage Repair Market.

more...

Orthopedic Biomaterials Market Size, Share and COVID-19 Impact Analysis | Global | 2023-2029 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more

Overall, the global orthopedic biomaterials device market was valued at $5.6 billion in 2022. This is expected to increase over the forecast period at a CAGR of 3.4% to reach $7.1 billion.

more...

Orthopedic Biomaterials Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Orthopedic Bone Graft Substitutes (Allografts, Demineralized Bone Matrices (DBMs), Xenografts, and Synthetic Bone Graft) , Orthopedic Growth Factor, and 4 more

Overall, the U.S. Orthopedic Biomaterials market was valued at $3.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $4.7 billion. Demographic factors in the U.S. continue to be the largest driver within the orthopedic biomaterials market. This is primarily due to the growing elderly

more...

Bone Graft Substitutes Market Size, Share, and COVID-19 Impact Analysis | Global | 2023-2029 | MedCore | Includes: Allograft BGS, Synthetic BGS, and 1 more

The full report suite on the global market for bone graft substitutes (BGS) includes allograft BGS, demineralized bone matrix allograft BGS and synthetic BGS. The market is further analyzed by unit type. Specifically, they are divided by nine types of indication: cervical, thoracolumbar spine, non-union trauma, fresh facture trauma, hip bone, knee bone, foot bone, craniomaxillofacial and oncology.

more...

Hyaluronic Acid Viscosupplementation Market Size, Share, and COVID-19 Impact Analysis | Global | 2023-2029 | MedCore | Includes: Single Injection, Two Injections, and 2 more

The full report suite on the global market for hyaluronic acid viscosupplementation includes single injection, two injections, three injections and five injections.

more...

Orthopedic Cell Therapy Market Size, Share, and COVID-19 Impact Analysis | Global | 2023-2029 | MedCore | Includes: Platelet-rich Cell Therapy and 1 more

The full report suite on the global market for orthopedic cell therapy includes platelet-rich cell therapy and bone marrow cell therapy.

more...

Orthopedic Growth Factor Market Size, Share, and COVID-19 Impact Analysis | Global | 2023-2029 | MedCore

Growth factors are a group of small, soluble proteins that bind onto cell surface receptors, triggering a series of signals that regulate the body’s ability to grow, renew and heal. Due to the regenerative properties of growth factors, they have been exploited for bone healing in orthopedic applications.

more...

Spinal Bone Graft Substitutes Market Analysis | Canada | 2016-2022 | MedCore

Bone graft substitute products are utilized by dentists/periodontitis, neurosurgeons and orthopedic surgeons. Orthopedic indications represent the most major portion of the bone graft substitute market, with spinal fusions representing the most major category of surgery within that realm. For the purpose of this report, we do not assess the dental bone graft substitute market in any way. Instead, we focus on spinal indications for bone grafts and its size relative to the bone graft substitute market (excluding dental indications).

more...